Diabetes Mellitus Type 2 Pathophysiology

Type 2 diabetes is caused by either inadequate production of the hormone insulin or a lack of response to insulin by various cells of the body.

Normal regulation of blood sugar

Glucose is an important source of energy in the body. It is mainly obtained from carbohydrates in the diet which are broken down into glucose for the various cells of the body to utilize. The liver is also able to manufacture glucose from its glycogen stores.

In a healthy person, a rise in blood sugar after a meal triggers the pancreatic beta cells to release the hormone insulin. Insulin, in turn, stimulates cells to take up the glucose from the blood. When blood glucose levels fall, during exercise for example, insulin levels also decline.

As well as insulin stimulating the uptake of glucose from the blood by body cells, it also induces the:

  • Stimulates the conversion of glucose to pyruvate (glycolysis) to release free energy
  • Conversion of excess glucose to glycogen for storage in the liver (glycogenesis)
  • Uptake and synthesis of amino acids, proteins, and fat

Pathology of type 2 diabetes

In type 2 diabetes, the body either produces inadequate amounts of insulin to meet the demands of the body or insulin resistance has developed. Insulin resistance refers to when cells of the body such as the muscle, liver and fat cells fail to respond to insulin, even when levels are high. In fat cells, triglycerides are instead broken down to produce free fatty acids for energy; muscle cells are deprived of an energy source and liver cells fail to build up glycogen stores.

This also leads to an overall rise in the level of glucose in the blood. Glycogen stores become markedly reduced and there is less glucose available for release when it may be needed. Obesity and lack of physical activity are thought to be major causes of insulin resistance.

Further Reading

Last Updated: Jul 3, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 03). Diabetes Mellitus Type 2 Pathophysiology. News-Medical. Retrieved on November 11, 2024 from https://www.news-medical.net/health/Diabetes-Mellitus-Type-2-Pathophysiology.aspx.

  • MLA

    Mandal, Ananya. "Diabetes Mellitus Type 2 Pathophysiology". News-Medical. 11 November 2024. <https://www.news-medical.net/health/Diabetes-Mellitus-Type-2-Pathophysiology.aspx>.

  • Chicago

    Mandal, Ananya. "Diabetes Mellitus Type 2 Pathophysiology". News-Medical. https://www.news-medical.net/health/Diabetes-Mellitus-Type-2-Pathophysiology.aspx. (accessed November 11, 2024).

  • Harvard

    Mandal, Ananya. 2023. Diabetes Mellitus Type 2 Pathophysiology. News-Medical, viewed 11 November 2024, https://www.news-medical.net/health/Diabetes-Mellitus-Type-2-Pathophysiology.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes